DE602005022862D1 - Bioaktive biomaterialien zur kontrollierten wirkstofffreisetzung - Google Patents

Bioaktive biomaterialien zur kontrollierten wirkstofffreisetzung

Info

Publication number
DE602005022862D1
DE602005022862D1 DE602005022862T DE602005022862T DE602005022862D1 DE 602005022862 D1 DE602005022862 D1 DE 602005022862D1 DE 602005022862 T DE602005022862 T DE 602005022862T DE 602005022862 T DE602005022862 T DE 602005022862T DE 602005022862 D1 DE602005022862 D1 DE 602005022862D1
Authority
DE
Germany
Prior art keywords
biomaterials
covalently linked
active ingredients
substituted
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005022862T
Other languages
English (en)
Inventor
Marie-Christine Durrieu
Damien Quemener
Charles Vincent Baquey
Valerie Sabaut-Heroguez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite des Sciences et Tech (Bordeaux 1)
Ecole National Superieure dArts et Metiers ENSAM
Ecole Nationale Superieure de Chimie et de Physique de Bordeaux
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite des Sciences et Tech (Bordeaux 1)
Ecole National Superieure dArts et Metiers ENSAM
Ecole Nationale Superieure de Chimie et de Physique de Bordeaux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM, Universite des Sciences et Tech (Bordeaux 1), Ecole National Superieure dArts et Metiers ENSAM, Ecole Nationale Superieure de Chimie et de Physique de Bordeaux filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE602005022862D1 publication Critical patent/DE602005022862D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
DE602005022862T 2004-06-21 2005-06-21 Bioaktive biomaterialien zur kontrollierten wirkstofffreisetzung Active DE602005022862D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0406708A FR2871701B1 (fr) 2004-06-21 2004-06-21 Biomateriaux bioactifs pour le relarguage controle de principes actifs
PCT/FR2005/001545 WO2006008386A1 (fr) 2004-06-21 2005-06-21 Biomateriaux bioactifs pour le relargage controle de principes actifs

Publications (1)

Publication Number Publication Date
DE602005022862D1 true DE602005022862D1 (de) 2010-09-23

Family

ID=34946356

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005022862T Active DE602005022862D1 (de) 2004-06-21 2005-06-21 Bioaktive biomaterialien zur kontrollierten wirkstofffreisetzung

Country Status (8)

Country Link
US (1) US20080004398A1 (de)
EP (1) EP1758621B1 (de)
JP (1) JP5383039B2 (de)
AT (1) ATE477007T1 (de)
DE (1) DE602005022862D1 (de)
ES (1) ES2350527T3 (de)
FR (1) FR2871701B1 (de)
WO (1) WO2006008386A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3360509B1 (de) * 2006-07-31 2022-06-22 Syntheon TAVR, LLC Verschliessbare endovaskuläre implantate
US9408607B2 (en) * 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
WO2010033726A2 (en) * 2008-09-17 2010-03-25 The Brigham And Women's Hospital, Inc. Drug delivery composition comprising a self-assembled gelator
EP4079292A1 (de) 2010-09-24 2022-10-26 The Brigham and Women's Hospital, Inc. Zur kontrollierten freisetzung verkapselter mittel fähige nanostrukturierte gele
WO2012091965A1 (en) 2010-12-17 2012-07-05 Carnegie Mellon University Electrochemically mediated atom transfer radical polymerization
US20140275420A1 (en) * 2011-08-22 2014-09-18 Carnegie Mellon University Atom transfer radical polymerization under biologically compatible conditions
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
EP3034538A1 (de) 2014-12-18 2016-06-22 Universite De Bordeaux Polymerteilchen und Biomaterialien damit
JP2018502953A (ja) * 2014-12-18 2018-02-01 ユニヴェルシテ・ドゥ・ボルドー ポリマー粒子及びそれを含む生体材料
US9982070B2 (en) 2015-01-12 2018-05-29 Carnegie Mellon University Aqueous ATRP in the presence of an activator regenerator
JP7121654B2 (ja) 2015-10-08 2022-08-18 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 被包した薬剤の送達のための安定化させた集合ナノ構造体
CN115837006A (zh) 2016-05-06 2023-03-24 布里格姆及妇女医院股份有限公司 用于向软骨中受控递送被囊封的药剂的二元自组装凝胶
WO2018132582A1 (en) 2017-01-12 2018-07-19 Carnegie Mellon University Surfactant assisted formation of a catalyst complex for emulsion atom transfer radical polymerization processes
US11020410B2 (en) 2017-02-03 2021-06-01 The Brigham And Women's Hospital, Inc. Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
EP3621594A1 (de) 2017-05-08 2020-03-18 Alivio Therapeutics, Inc. Formulierung von nanostrukturierten gelen für erhöhte wirkstoffladung und adhäsion
US11839605B2 (en) 2018-10-11 2023-12-12 Alivio Therapeutics, Inc. Non-injectable hydrogel formulations for smart release

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791189A (en) * 1987-05-07 1988-12-13 The B. F. Goodrich Company Terminally unsaturated macromolecular monomers of polylactones and copolymers thereof
US5356433A (en) * 1991-08-13 1994-10-18 Cordis Corporation Biocompatible metal surfaces
US5607475A (en) * 1995-08-22 1997-03-04 Medtronic, Inc. Biocompatible medical article and method
WO2000033079A1 (en) * 1998-11-30 2000-06-08 Nanosphere, Inc. Nanoparticles with polymer shells
JP2005518827A (ja) * 2001-10-05 2005-06-30 サーモディクス，インコーポレイテッド 粒子固定化コーティングおよびその使用
EP1371699A3 (de) * 2002-06-14 2004-01-14 Rohm And Haas Company Polymere Nanopartikel und antimikrobielle Beschichtungsformulierungen

Also Published As

Publication number Publication date
ES2350527T3 (es) 2011-01-24
JP5383039B2 (ja) 2014-01-08
WO2006008386A1 (fr) 2006-01-26
FR2871701A1 (fr) 2005-12-23
US20080004398A1 (en) 2008-01-03
EP1758621B1 (de) 2010-08-11
EP1758621A1 (de) 2007-03-07
FR2871701B1 (fr) 2006-09-22
JP2008503553A (ja) 2008-02-07
ATE477007T1 (de) 2010-08-15

Similar Documents

Publication Publication Date Title
DE602005022862D1 (de) Bioaktive biomaterialien zur kontrollierten wirkstofffreisetzung
Li et al. Mineral-enhanced polyacrylic acid hydrogel as an oyster-inspired organic–inorganic hybrid adhesive
Ahn Perspectives on mussel-inspired wet adhesion
Wei et al. Bridging adhesion of mussel-inspired peptides: Role of charge, chain length, and surface type
GhavamiNejad et al. In situ synthesis of antimicrobial silver nanoparticles within antifouling zwitterionic hydrogels by catecholic redox chemistry for wound healing application
Lu et al. Mussel-inspired thermoresponsive polypeptide–pluronic copolymers for versatile surgical adhesives and hemostasis
Lee et al. Phase controllable hyaluronic acid hydrogel with iron (III) ion–catechol induced dual cross-linking by utilizing the gap of gelation kinetics
Sagnella et al. Chitosan based surfactant polymers designed to improve blood compatibility on biomaterials
Li et al. Surface modification of silicone for biomedical applications requiring long-term antibacterial, antifouling, and hemocompatible properties
Perlin et al. Production and performance of biomaterials containing RGD peptides
Yoo et al. Cooperative catechol-functionalized polypept (o) ide brushes and Ag nanoparticles for combination of protein resistance and antimicrobial activity on metal oxide surfaces
HK1135609A1 (en) Formation of medically useful gels comprising microporous particles and methods of use
DE602005017903D1 (de) Mittels wasserabweisender implantate mit anionischer ladung funktionalisierte polyaminosäuren und anwendungen, wie etwa therapeutische anwendungen dafür
Zhang et al. Adhesive, antibacterial, conductive, anti-UV, self-healing, and tough collagen-based hydrogels from a pyrogallol-Ag self-catalysis system
Xu et al. Arginine-based polymer brush coatings with hydrolysis-triggered switchable functionalities from antimicrobial (Cationic) to antifouling (Zwitterionic)
DE602005015696D1 (de) Resorbierbare biokompatible beschichtungen
Mauro et al. RGD‐mimic polyamidoamine–montmorillonite composites with tunable stiffness as scaffolds for bone tissue‐engineering applications
Peng et al. Scarless wound closure by a mussel-inspired poly (amidoamine) tissue adhesive with tunable degradability
Chan et al. Poly (ethylene glycol)‐modulated cellular biocompatibility of polyhydroxyalkanoate films
Xu et al. Multifunctional biomaterial coating based on bio-inspired polyphosphate and lysozyme supramolecular nanofilm
Page et al. Promoting cell adhesion on slippery phosphorylcholine hydrogel surfaces
Suneetha et al. Cell/Tissue Adhesive, Self‐Healable, Biocompatible, Hemostasis, and Antibacterial Hydrogel Dressings for Wound Healing Applications
ATE487750T1 (de) Stimulierbare polymerpartikel mit reaktiven funktionen, verfahren zur herstellung dafür und verwendung damit
Yan et al. Adhesive Gelatin-Catechol complex reinforced poly (Acrylic Acid) hydrogel with enhanced toughness and cell affinity for cartilage regeneration
Sun et al. Inspired by the periodontium: a universal bacteria-defensive hydrogel for preventing percutaneous device-related infection